1+ week, 3+ day ago   (594+ words) Health & Science Correspondent South Africa’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has pulled out of government plans for local production of Gilead Sciences’ HIV prevention shot lenacapavir, citing a lack of guaranteed demand, and is instead targeting Merck’s experimental pill, alimatravir....

1+ week, 5+ day ago   (661+ words) Health & Science Correspondent Lindiwe Mqatazana is not taking any chances with her health, or with that of her unborn child. “There’s a lot of guys who won’t tell you they are HIV positive. So I have to protect myself,” says…...

3+ week, 3+ day ago   (417+ words) Health & Science Correspondent The US National Institutes of Health (NIH) has ended its ban on funding South African research projects, opening the door for local scientists to apply for its grants once more. In a memo sent to staff, a…...

3+ week, 5+ day ago   (685+ words) Health & Science Correspondent The health department has pushed back against pharmaceutical manufacturer Cipla’s legal bid to scrap its R15.5bn Aids drug tender, arguing in court papers that officials ran a fair and rational process to determine which companies should be allocated…...